Did you know a huge opportunity awaits you in molecular point-of-care flu testing? In this brief, 3 minute podcast excerpt, Repertoire’s Scott Adams, Moses Odria, Henry Schein Field Sales Consultant, TX and representatives from Sekisui Diagnostics discuss molecular testing and its impact on patient outcomes, the advantages for practices, how easy it is to sell molecular tests – and why you shouldn’t be afraid to bring it to your accounts.